tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Leerink sees potential for ‘reset’ in Hims & Hers with Ozempic shortage ended
The FlyLeerink sees potential for ‘reset’ in Hims & Hers with Ozempic shortage ended
23h ago
NVO
HIMS
FDA not taking action against weight loss compounders for violations
PremiumThe Fly
FDA not taking action against weight loss compounders for violations
23h ago
NVO
HIMS
FDA declares Wegovy and Ozempic shortage over, Novo Nordisk confirms
PremiumThe Fly
FDA declares Wegovy and Ozempic shortage over, Novo Nordisk confirms
23h ago
NVO
Novo Nordisk up 6%, Hims & Hers down 15% as FDA says Ozempic shortage over
PremiumThe Fly
Novo Nordisk up 6%, Hims & Hers down 15% as FDA says Ozempic shortage over
1d ago
LLY
NVO
Novo Nordisk call volume above normal and directionally bullish
PremiumThe Fly
Novo Nordisk call volume above normal and directionally bullish
4d ago
NVO
CVS Health, Lyft report Q4 results: Morning Buzz
PremiumThe FlyCVS Health, Lyft report Q4 results: Morning Buzz
10d ago
Z
MU
Low doses of Ozempic help to reduce alcohol consumption, Bloomberg reports
Premium
The Fly
Low doses of Ozempic help to reduce alcohol consumption, Bloomberg reports
10d ago
NVO
Novo Nordisk initiated with an Equal Weight at Morgan Stanley
Premium
The Fly
Novo Nordisk initiated with an Equal Weight at Morgan Stanley
10d ago
NVO
Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
PremiumThe Fly
Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
11d ago
NVO
GMAB
Hims & Hers jumps ahead of controversial Super Bowl ad airing
PremiumThe Fly
Hims & Hers jumps ahead of controversial Super Bowl ad airing
15d ago
LLY
NVO
Viking Therapeutics price target lowered to $70 from $120 at Maxim
PremiumThe Fly
Viking Therapeutics price target lowered to $70 from $120 at Maxim
15d ago
LLY
NVO
Novo Nordisk price target lowered to DKK 1,000 from DKK 1,050 at JPMorgan
PremiumThe Fly
Novo Nordisk price target lowered to DKK 1,000 from DKK 1,050 at JPMorgan
16d ago
NVO
Unusually active option classes on open February 5th
PremiumThe FlyUnusually active option classes on open February 5th
17d ago
ACB
CGC
0QIU Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
0QIU Earnings this Week: How Will it Perform?
19d ago
TNF Pharmaceuticals to study TNF-alpha in patients taking GLP-1s
Premium
The Fly
TNF Pharmaceuticals to study TNF-alpha in patients taking GLP-1s
24d ago
NVO
TNFA
Novo Nordisk announces FDA approval of Ozempic for kidney disease risk
PremiumThe Fly
Novo Nordisk announces FDA approval of Ozempic for kidney disease risk
25d ago
NVO
Contact Levi & Korsinsky LLP by March 25, 2025 Deadline to Join Class Action Against Novo Nordisk A/S(NVO)
PremiumClass Action
Contact Levi & Korsinsky LLP by March 25, 2025 Deadline to Join Class Action Against Novo Nordisk A/S(NVO)
29d ago
NVO
Novo Nordisk criticized for not disclosing payments to health groups, STAT says
PremiumThe Fly
Novo Nordisk criticized for not disclosing payments to health groups, STAT says
29d ago
NVO
Unusually active option classes on open January 24th
PremiumThe Fly
Unusually active option classes on open January 24th
29d ago
MA
NU
Morning Movers: American Express and Verizon trend higher following Q4 results
PremiumThe FlyMorning Movers: American Express and Verizon trend higher following Q4 results
29d ago
BA
VZ
Novo Nordisk amycretin data helps rebut concerns, says BofA
Premium
The Fly
Novo Nordisk amycretin data helps rebut concerns, says BofA
29d ago
NVO
Novo Nordisk shares jump on phase 1b/2a subcutaneous amycretin trial results
Premium
The Fly
Novo Nordisk shares jump on phase 1b/2a subcutaneous amycretin trial results
29d ago
NVO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >